155 related articles for article (PubMed ID: 8299667)
1. Positive correlation between probucol in low density lipoprotein and LDL-lowering.
Shinomiya M; Shirai K; Saito Y; Yoshida S
Eur J Clin Pharmacol; 1993; 45(4):343-6. PubMed ID: 8299667
[TBL] [Abstract][Full Text] [Related]
2. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
[TBL] [Abstract][Full Text] [Related]
3. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
Dachet C; Jacotot B; Buxtorf JC
Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
[TBL] [Abstract][Full Text] [Related]
4. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
Tomikawa M; Nakayasu T; Tawara K; Abiko Y
Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
Harada N; Kashiwagi A; Nishio Y; Kikkawa R
Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
[TBL] [Abstract][Full Text] [Related]
6. The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
Atmeh RF; Stewart JM; Boag DE; Packard CJ; Lorimer AR; Shepherd J
J Lipid Res; 1983 May; 24(5):588-95. PubMed ID: 6875383
[TBL] [Abstract][Full Text] [Related]
7. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
Cortese C; Marenah CB; Miller NE; Lewis B
Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
[TBL] [Abstract][Full Text] [Related]
8. Effects of probucol on lipoprotein protein kinetics.
Nestel PJ
Artery; 1982; 10(2):95-8. PubMed ID: 7092582
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term treatment with probucol on serum lipoproteins in cases of familial hypercholesterolemia in the elderly.
Morisaki N; Mori S; Kobayashi J; Ishikawa Y; Shinomiya M; Shirai K; Saito Y; Yoshida S
J Am Geriatr Soc; 1990 Jan; 38(1):15-8. PubMed ID: 2295765
[TBL] [Abstract][Full Text] [Related]
10. Probucol reduces lysophosphatidylcholines in low-density lipoprotein.
Yoshinari M; Shi AH; Yoshizumi H; Wakisaka M; Iwase M; Fujishima M
Eur J Clin Pharmacol; 2000; 55(11-12):787-92. PubMed ID: 10805055
[TBL] [Abstract][Full Text] [Related]
11. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein fractions and receptors: a role for probucol?
Bilheimer DW
Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
[TBL] [Abstract][Full Text] [Related]
13. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
Reaven PD; Parthasarathy S; Beltz WF; Witztum JL
Arterioscler Thromb; 1992 Mar; 12(3):318-24. PubMed ID: 1547191
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
[TBL] [Abstract][Full Text] [Related]
15. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
16. Mode of hypocholesterolemic action of probucol in animals and man.
Beynen AC
Artery; 1987; 14(2):113-26. PubMed ID: 3551883
[TBL] [Abstract][Full Text] [Related]
17. Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
Trezzi E; Roma P; Bernini F; Fumagalli R; Catapano AL
Atherosclerosis; 1984 Sep; 52(3):309-16. PubMed ID: 6093829
[TBL] [Abstract][Full Text] [Related]
18. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
[TBL] [Abstract][Full Text] [Related]
20. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
Lauridsen ST; Mortensen A
Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
